Oclacitinib Maleate
CAS: 1640292-55-2
Ref. 3D-QQC29255
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
Oclacitinib Maleate is an orally-bioavailable small molecule drug candidate that inhibits the activity of the protein tyrosine kinase, which is a key signaling molecule in many cancers. Studies have shown that oclacitinib binds to the phosphate group on the ATP-binding site of the enzyme, preventing it from binding to its receptor. Oclacitinib has been shown to be safe and well tolerated for long-term use in diabetic patients. This drug has also been shown to inhibit PDL1 expression and inhibit insulin-like growth factor 1 (IGF1).
Chemical properties
Technical inquiry about: 3D-QQC29255 Oclacitinib Maleate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
